NEW YORK (GenomeWeb News) — OncoMethylome Sciences hopes to raise around €8 million ($11.3 million) or more after issuing a private offering of new shares to institutional and qualified investors, the company said today.
However, the Belgian gene methylation-testing shop said it will not sell more than 10 percent of its outstanding shares.
OncoMethylome said it plans to use the funds to pursue clinical trials for its cancer diagnostics and tests for targeted cancer treatments.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The United Nations is to consider a ban on field testing gene drives at a meeting being held next week, Technology Review reports.

The Associated Press reports that gene-edited food may soon be for sale.

The US Department of Health and Human Services is beginning a series of meetings on human fetal tissue research, Stat News reports.

In Cell this week: epigenetic change linked to glioblastomas, rare and low-frequency variants contributing to multiple sclerosis risk, and more.